Altre lingue Avadel Pharmaceuticals plc

Azioni

AVDL

IE00BDGMC594

Prodotti farmaceutici

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 17/01/2025			Variaz. 5gg	Var. 1 gen.
7,750 ^USD	-3,12%		-1,90%	-26,26%

13/01	AVADEL PHARMACEUTICALS PLC : giudizio positivo da UBS	ZM
10/01	I principali ribassisti del mercato	MT

Altre lingue

Top Premarket Decliners	10/01
Avadel Pharmaceuticals Preliminary Q4 Net Product Revenue Rises; 2025 Outlook Set; Shares Fall After Hours	08/01
Avadel Pharmaceuticals plc Provides Update on Revitalyz Pivotal Study	08/01
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch	08/01
Avadel Pharmaceuticals plc Provides Earnings Guidance for 2025	08/01
Avadel Announces Grant of Inducement Awards under Nasdaq Listing Rule 5635(4)	07/01
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)	06/01
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8	06/01
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8	03/01
Avadel Pharmaceuticals - Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy	12/12
Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy	11/12
Avadel Pharmaceuticals plc Announces Step Down of Richard Kim as Chief Commercial Officer Effective as of December 31, 2024	03/12
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference	13/11
Avadel Pharmaceuticals : Provides Corporate Update and Reports Third Quarter 2024 Financial Results Form 8 K	12/11
Avadel Pharmaceuticals' Q3 Loss Narrows, Revenue Rises	12/11
Avadel: Q3 Earnings Snapshot	12/11
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results	12/11
Avadel Pharmaceuticals plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	12/11
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12	04/11
Avadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz Litigation	31/10/24
Wall Street Set to Open Lower Thursday; Inflation Data Meets Expectations, Initial Jobless Claims Decline	31/10/24
Investors Await Key Inflation, Employment Data as US Futures Move Lower in Thursday's Premarket	31/10/24
Top Premarket Gainers	31/10/24
Avadel Pharmaceuticals : Announces Favorable Ruling in Administrative Procedure Act Litigation Form 8 K	31/10/24
Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation	31/10/24

Iscriviti per accedere a più notizie

Registrazione 100% gratuita

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Avadel Pharmaceuticals plc

Azioni

AVDL

IE00BDGMC594

Prodotti farmaceutici

Altre lingue

Filtri